Phio Pharmaceuticals Corp.
PHIO
Positions held
Your positionsPHIO isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $11.30M | Enterprise value | -$1.69M | Trailing P/E | — | Forward P/E | -1.60 |
| PEG | — | Price / book | 0.90 | Beta | 0.84 | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | 0.0% | Operating margin | 0.0% |
| Profit margin | 0.0% | ROE | -113.7% | ROA | -65.8% | Debt / equity | — |
| Current ratio | 8.39 | Free cash flow | -$7.72M | Analyst recommendation | none | Mean target | $14.00 |
| 52w high | $4.19 | 52w low | $0.81 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — | — |
| Net income | -$4.1M | -$4.0M | -$2.4M | -$2.4M | -$2.2M | — |
| Gross margin | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$4.3M | -$4.2M | -$2.5M | -$2.5M | -$2.3M | — |
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — |
| Net income | -$8.7M | -$7.2M | -$10.8M | -$11.5M | — |
| Gross margin | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$9.2M | -$7.4M | -$10.7M | -$11.5M | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-06 · Phio Pharmaceuticals to Present at The Global Markets Virtual Forum October 8, 2026
2026-10-05 · OTC Markets Group Announces Agenda for Third Annual Global Markets Forum, October 7th & 8th
2026-10-05 · Phio Pharmaceuticals to Present at the National Investment Banking Association (NIBA) 153rd Conference
2026-09-11 · Phio Pharmaceuticals to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
2026-08-06 · Phio Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Update
2026-07-21 · Phio Pharmaceuticals Announces Appointment of Dr. R. Todd Plott to the Board of Directors
2026-07-15 · Phio Pharmaceuticals Expands Global Patent Portfolio With New International Patent Milestones
Price (daily)
Full chart · RSI · MACD · patterns